StockIQpro
NASDAQ:SIBN

SI-BONE, Inc.

Track all markets on TradingView
Track all markets on TradingView

SI-BONE, Inc.'s revenue grew 20.2% in fiscal 2025 to $200.9M while operating margin rose to −11.1%, its highest in 9 years. Free cash flow was −$9.1M, −4.5% of revenue, and the diluted share count rose 3.6%.Summary generated from SI-BONE, Inc.'s SEC filings. Latest annual report filed Feb 24, 2026.

Key statistics

Fiscal 2025 from SEC filings. Methodology
Revenue (FY25)$200.9M
Revenue growth+20.2%
Revenue, 5-yr CAGR+22.3%
Gross margin79.6%
Operating margin−11.1%
Net margin−9.4%
ROIC−10.4%
Return on equity−11.0%
Debt / equity0.20
Free cash flow−$9.1M
FCF margin−4.5%
Share count change+3.6%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue90106139167201
Operating income−52−60−47−35−22
Net income−57−61−43−31−19
Free cash flow−46−51−27−23−9

Recent filings

From SEC EDGAR

Peers

Surgical & medical instruments & apparatus